O

OncoSenX

12 employees

OncoSenX is a developer of transient gene therapies designed for solid tumors.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care

Date founded

2017

Funding rounds raised

Total raised

$4.5M

from 5 investors over 5 rounds

O

OncoSenX raised undisclosed on January 29, 2021

Investors: Althea Group

O

OncoSenX raised $4.2M on July 2, 2020

Investors: Canadian Institutes of Health Research | Instituts de recherche en santé du Canada

O

OncoSenX raised $4.5M on April 1, 2020

Investors: SENS Research Foundation and Helios Capital

O

OncoSenX raised undisclosed on December 1, 2017

Investors: Avant Global, LLC

FAQ